Azapropazone or allopurinol in the treatment of chronic gout and/or hyperuricaemia. A preliminary report
Templeton, J.S.
British Journal of Clinical Practice 36(10): 353-358
1982
ISSN/ISBN: 0007-0947 PMID: 7171423 Document Number: 186132
Document emailed within 1 workday
Related Documents
Dunky, A.; Nitsche, V.; Eberl, R. 1981: Therapeutic efficacy of slow-release allopurinol in gout and hyperuricaemia Wiener Klinische Wochenschrift 93(2): 65-68Naas, J.E.; Sanders, L.J. 1998: Chronic tophaceous gout in a patient with a history of allopurinol toxicity Cutis 62(5): 239-241
Faust-Tinnefeldt, G.F.; Geissler, H.E. 1978: Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone Arzneimittel-Forschung 28(2): 337-341
Yoshimura, T.; Akaoka, I.; Nishizawa, T.; Nishida, T. 1973: Long-term treatment of 20 cases of gout with allopurinol Ryumachi 13(2): 168-182
Lowenthal, M.N.; Dymond, I.D. 1977: Gout and hyperuricaemia in Blacks South African Medical Journal 52(21): 832
Meyers, O.L.; Cassim, B.; Mody, G.M. 2003: Hyperuricaemia and gout: clinical guideline 2003 South African Medical Journal 93(12 Part 2): 961-971
Ohno, I.; Okabe, H.; Yamaguchi, Y.; Saikawa, H.; Uetake, D.; Hikita, M.; Gomi, H.; Ichida, K.; Hosoya, T. 2008: Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol Nihon Jinzo Gakkai Shi 50(4): 506-512
Boyle, J.A.; Greene, M.L.; Seegmiller, J.E. 1971: Alterations in the activity of hypoxanthine and adenine phosphoribosyltransferase in patients with hyperuricaemia and gout Quarterly Journal of Medicine 40(160): 574-575
Frank, O. 1974: Investigations concerning the incidence of disorders of lipid and carbohydrate metabolism in primary gout and symptomless hyperuricaemia Wiener Klinische Wochenschrift 86(9): 252-256
Akizuki, S. 1982: A population study of hyperuricaemia and gout in Japan--analysis of sex, age and occupational differences in thirty-four thousand people living in Nagano Prefecture Ryumachi 22(3): 201-208
Richette, P.; Brière, C.; Hoenen-Clavert, V.; Loeuille, D.; Bardin, T. 2007: Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study Journal of Rheumatology 34(10): 2093-2098
Schuster, O.; Haertel, M.; Hugemann, B.; Gikalov, I.; Schiemann, O.; Fenner, H. 1985: The clinical pharmacokinetics of allopurinol. 1. Allopurinol absorption sites and dose proportionality of allopurinol/oxipurinol bioavailability Arzneimittel-Forschung 35(4): 760-765
Kouroumalis, E.A.; Koskinas, J. 1986: Treatment of chronic active hepatitis B (CAH B) with chloroquine: a preliminary report Annals of the Academy of Medicine Singapore 15(2): 149-152
Matzkies, F. 1983: Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone Fortschritte der Medizin 101(20): 953-959
Shi, X.F.; Xu, D.; Shuai, Z.W. 2018: Frequently asked questions of gout(2): prophylaxis and treatment of acute gout Zhonghua Nei Ke Za Zhi 57(10): 759-760
Akizuki, S. 1981: A population study on hyperuricaemia by multivariate analysis - analysis of factors concerning hyperuricaemia by the linear discriminant function test Ryumachi 21(3): 173-184
Sellitto, A.; De Fanis, U.; Balestrieri, A.; Savoia, A.; Astarita, C.; Romano, C. 2017: Effects of omalizumab treatment on serum cytokine concentrations of atopic patients with chronic spontaneous urticaria: a preliminary report European Annals of Allergy and Clinical Immunology 49(4): 171-175
Saigal, S.; Agarwal, S.R.; Nandeesh, H.P.; Sarin, S.K. 2001: Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: A preliminary report Journal of Gastroenterology and Hepatology 16(9): 1028-1032
Satirapoj, B.; Wirajit, O.; Burata, A.; Supasyndh, O.; Ruangkanchanasetr, P. 2015: Benefits of Allopurinol Treatment on Blood Pressure and Renal Function in Patients with Early Stage of Chronic Kidney Disease Journal of the Medical Association of Thailand 98(12): 1155-1161
Kawenoki-Minc, E. 1970: Effect of allopurinol on the course of gout. Biological and biochemical properties, metabolism in living organisms, effect on the purine metabolism Polski Tygodnik Lekarski 25(15): 544-546